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Objectives: In the context of comparisons of surgical outcomes, risk adjustment is the retrospective
adjustment of a provider's or a surgeon's results for case mix and/or hospital volume. It allows accurate,
meaningful inter-provider comparison. It is therefore an essential component of any audit and quality
improvement process. The aim of this study was to review the literature to identify those factors known
to affect prognosis in hepatobiliary and pancreatic cancer surgery.
Methods: PubMed was used to identify studies assessing risk in patients undergoing resection surgery,
rather than bypass surgery, for hepatobiliary and pancreatic cancer.
Results: In total, 63 and 68 papers, pertaining to 24 609 and 63 654 patients who underwent hepatic
or pancreatic resection for malignancy, respectively, were identified. Overall, 22 generic preoperative
factors predicting outcome on multivariate analysis, including demographics, blood results, preoperative
biliary drainage and co-morbidities, were identified, with tumour characteristics proving disease-specific
factors. Operative duration, transfusion, operative extent, vascular resection and additional intra-
abdominal procedures were also found to be predictive of early outcome.
Conclusions: The development of a risk adjustment model will allow for the identification of those
factors with most influence on early outcome and will thus identify potential targets for preoperative
optimization and allow for the development of a multicentre risk prediction model.
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Introduction
There has been increasing pressure for open scrutiny into treat-
ment outcomes over the last decade. Largely triggered by the
Bristol Royal Infirmary Inquiry into paediatric cardiac deaths,1
monitoring of performance has now become a statutory respon-
sibility for National Health Service (NHS) organizations.2 There
has also been a realization that validated quality assessment is
necessary for results to improve. In general, medical outcome data
such as mortality and length of hospital stay are used to evaluate
quality of care and compare treatment providers.3 These measures
are objective and can readily be used to audit results within a
centre or between institutions; however, the availability of surgical
results to the general public can cause great controversy and may
result in the denial of surgery to ‘high-risk’ patients.4
Health care outcome is influenced by factors other than the
health care team, including patient lifestyle, co-morbidity and
severity of disease.5,6 As patients are not randomized between
centres, differing population characteristics between centres may
result in patterns of outcome that are misleading purely as a result
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of case mix. Misleading information may subsequently lead to
inappropriate decision making and risk-shy behaviour. This has
all resulted in an increasing interest in quality assessment meth-
odology, particularly in risk adjustment. Risk adjustment in this
context refers to the retrospective adjustment of a provider’s or a
surgeon’s results for case mix and/or hospital volume and allows
for accurate, meaningful inter-provider comparison.7,8 It is there-
fore an essential component of any audit and quality improve-
ment process.
Partly because of the high-profile, high-cost nature of the
surgery, and also as a result of the Bristol Inquiry, the lead in
publication of results and risk modelling has been taken by
cardiothoracic surgeons.9 Hepatobiliary and pancreatic cancer
surgery is similar in that it involves high-cost, high-risk surgery.
Few risk adjustment models exist and the generic models such as
POSSUM have been found to consistently over-predict operative
mortality.10–12 Risk models derived from databases of general
surgical operations are likewise inappropriate for application to
hepatobiliary and pancreatic surgery as it is well established that
the type of operation is a significant predictive factor.13,14 The
performance of risk models has been shown to be reduced when
applied to an extraneous population.15 Reasons for this may
include differences in clinical practices, resources and critical care
support.
Models should take into account the population mix and
disease burden; these requirements make models developed in
other parts of the world unsuitable for application to a European
population.
In recognition of the importance of quality assessment and
appropriate risk adjustment, and following on from the work of
our cardiothoracic colleagues, the Association of Upper Gas-
trointestinal Surgeons of Great Britain and Ireland (AUGIS) has
commissioned a national database to audit the results of hepato-
biliary and pancreatic cancer surgery performed in the UK. The
aim of this study was to review the literature to identify those
factors known to affect prognosis in hepatobiliary and pancreatic
cancer surgery. This will ensure the collection of appropriate data
fields and the creation of a hepatopancreaticobiliary cancer risk
adjustment model, which will facilitate the meaningful inter-
pretation of data collected from multiple institutions in the UK.
Materials and methods
Search strategy
An electronic literature search was conducted using the PubMed
andWeb of Knowledge databases as the primary sources. No time
limits were specified up to the date of the search (1 June 2009).
The main search terms used were: ‘hepatic cancer’, ‘hepatic
metastases’, ‘pancreatic cancer’, ‘gallbladder cancer’, ‘cholangiocar-
cinoma’, ‘ampullary carcinoma’, ‘periampullary carcinoma’, ‘surgi-
cal risk’, ‘operative risk’, ‘risk adjustment’, ‘perioperative risk’ and
‘perioperative outcome’. Specific search criteria are given in the
Appendix. Cited references in articles identified were used to
find further relevant publications. The search was restricted to
English-language publications. Studies published in abstract form
only, unpublished studies and articles published in non-peer-
reviewed journals were not included.
Selection process
Abstracts from potentially relevant articles were scanned for
eligibility and the full text of relevant articles was reviewed.
All articles that examined perioperative risk using multivariate
analysis were included. Only studies that assessed risk in patients
undergoing resection surgery, rather than bypass surgery, were
included. All data collected examined routinely collected pre-
operative information that was well defined and unambiguous.
Data extraction
Information collected included patient numbers, tumour type,
operation performed, morbidity rate, mortality rate, complica-
tions, length of hospital stay, and predictors of perioperative
outcome on multivariate analysis. Only factors that were identi-
fied as predictive inmore than one study were included in the final
analysis.
Study characteristics and results
Hepatic surgery
The initial search identified 9539 articles regarding perioperative
risk following resection for primary and metastatic hepatic
malignancy, including intrahepatic cholangiocarcinoma, Klatskin
tumours and gallbladder carcinoma. Of these, 9476 were rejected
at abstract stage, leaving 63 relevant papers that were subsequently
examined (a flow chart is displayed in the Appendix). Four of
these papers referred to multicentre studies16–19 and the remainder
reported single-centre studies and almost exclusively retrospective
series. The studies pertained to a total of 24 609 patients who
underwent hepatectomy, with a mean of 379 patients per study
(range 40–4661 patients). Forty-seven of these studies (75%)
reported mortality rates, giving a median mortality rate of 3.7%
(range 0–22.0%). Thirty-seven studies (58%) reported post-
operative morbidity rates, giving a median rate of 36.0% (range
12.5–66.0%). Forty-five (71%) reported reasons for resection,
indicating that 7882 resections were performed for hepatocellular
carcinoma (HCC), 3297 for colorectal liver metastases, 812
for intrahepatic cholangiocarcinoma, and 278 for gallbladder
carcinoma. Twenty-nine studies (46%) reported resections for
single pathologies only, including HCC (19 studies),12,17,20–36
colorectal metastasis (four studies),37–40 cholangiocarcinoma (four
studies)41–44 and gallbladder carcinoma (two studies).45,46 Thirty-
one studies (49%) reported the type of resection, indicating that a
median of 62% of procedures were major hepatic resections
(range 3–100%).
Ten studies investigated predictors of mortality, 23 examined
predictors of morbidity and 13 looked at both outcomes. Nine
studies investigated predictors of post-resection hepatic failure
and two looked for predictors of postoperative hospital stay.
Eighteen independent predictors of postoperative mortality were
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identified in the literature; 10 were preoperative factors, six were
perioperative and two were postoperative (Table 1). Sixteen inde-
pendent predictors of postoperative complications were identi-
fied; of these, 10 were preoperative and six were perioperative.
Two independent predictors of postoperative hepatic failure were
identified, namely: estimated residual liver volume and extent of
resection.
Pancreatic surgery
The initial search identified 7167 articles regarding perioperative
risk following pancreatic resection for malignancy, including
pancreatic adenocarcinoma, ampullary carcinoma and distal cho-
langiocarcinoma. Of these, 7099 were rejected at abstract stage,
leaving 68 relevant papers (a flow chart is displayed in the Appen-
dix). Fifteen of these papers reported multicentre studies47–61 and
the remainder referred to single-centre investigations. The studies
pertained to a total of 63 654 patients undergoing pancreatic
resection, with a mean of 936 patients per study (range 26–39 463
patients). Fifty-one studies (75%) reported mortality rates, giving
a median mortality rate of 4.1% (range 0–12.9%). Thirty-seven
studies (54%) reported postoperative morbidity rates, giving a
median rate of 43.5% (range 17.5–88.0%).
Twenty-six studies investigated predictors of morbidity,
11 investigated predictors of mortality, and 11 examined both
outcomes. Twenty-seven studies investigated predictors of post-
resection pancreatic fistula/anastomotic leak and five examined
postoperative hospital stay. Eleven independent predictors of
postoperative mortality were identified in the literature; of these,
six were preoperative factors, three were perioperative, and two
were postoperative (Table 2). Thirteen independent predictors
of postoperative complications were identified; eight of these
were preoperative and five were perioperative. Five independent
predictors of postoperative pancreatic fistula/anastomotic leak
were identified; of these, one was preoperative and four were
perioperative.
Discussion
The aim of theAUGIS hepatobiliary and pancreatic cancer surgery
audit is tomonitor outcomes following resection across theUKand
to allow the development of a risk adjustment model that will
facilitate the publication of high-quality data in the public domain.
In addition, it will allow the identification of those factors with
most influence on early outcomes and will thus identify potential
targets for preoperative optimization. Finally, the audit will allow
for the development of a multicentre risk prediction model which
may play a role in preoperative risk assessment and the allocation
of resources. A multicentre model will be more representative
of the UK population than a single-centre study and will generate
less selection bias. In addition, a UK-based model will avoid the
problems of reduced performance that arise when risk models are
transferred outwith their native populations.
Table 1 Summary of factors found to be independently predictive of adverse early outcome following hepatic resection for malignancy
Preoperative factors Perioperative factors Postoperative
factors
Mortality Hospital volume19,53
Pathology18,19
Age18,82–84
Sex19,45,85
Elevated bilirubin45,64,83,85
Low albumin30,41,43,86
Platelets36,83,86
Elevated serum creatinine85,86
Co-morbidity/number of co-morbidities19,26,84
Hepatic disease/cirrhosis18,82,87
Intraoperative blood loss30,83,85
Operative time64
Extent of resection18,19,38,41,45,83,84,86
Vascular resection45,85
Blood transfusion26,82,86–88
Pringle time >20 mins87,88
Bile leak87
Hepatic
impairment87
Postoperative
complications
Male sex83,89
Elevated bilirubin46,90–92
Serum albumin16,46,83
Abnormal clotting22,65,90,93,94
Low platelets22,36,86
Elevated serum urea63,95
Elevated serum creatinine63,83
Co-morbidity64,83,96
Diabetes mellitus22,63,95
Cardiovascular disease16
Intraoperative blood loss22,36,63–65,83,90,92,94,95,97,98
Operative time24,63,90,92,93,99
Extent of resection23,40,65,83,87,88,92,98,100
Extrahepatic procedure37,86,101,102
Blood transfusion22,26,36,37,40,46,82,86–88,91
Pringle time >20 mins26,87,88
Postoperative
hepatic failure
Estimated percentage of residual hepatic volume20,28,69
Extent of resection21,87
Bile leak Tumour number and location35,88,103 Extent/type of resection87,88,103
Blood transfusion87,88
Pringle time >20 mins87,88
Blood loss Tumour size27,32,34,104
Raised serum alanine transaminase (ALT)27,34
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The aim of this review was to identify factors known to influ-
ence outcome following hepatopancreaticobiliary cancer surgery.
These will then be incorporated into a risk adjustment model.
A model’s validity is dependent upon 95% completion and so the
completion of data fields is essential to the proper construction of
a risk adjustment model.62 It is therefore necessary that any data
are routinely collected and standardized between centres. Factors
such as indocyanine green retention (ICGR) at 15 mins,25,63 galac-
tose elimination,64 hyaluronic acid level,65,66 Karnofsky’s index,67
HbA1c68 and pancreatic time-signal curve on magnetic resonance
imaging68 are considered unlikely to be recorded in a uniform
manner across centres and are therefore not usefully included
in any model. Similarly, it is unlikely that data on estimated
residual liver volume,20,28,69 pancreatic texture,57,60,70–77 pancreatic
duct diameter47,71,73,77–80 and ‘congestion’ at the anastomotic site81
can be standardized across centres.
Many of the operative factors, such as blood loss, transfusion
and operating time, represent complications of surgery rather
than characteristics of the population itself. These factors are
therefore not appropriate for incorporation into a risk adjustment
model; however, the collection of these data is still valuable for the
purposes of auditing transfusion requirements, etc. A number of
the data fields refer to blood test results. Only findings that can be
obtained from routine preoperative tests for hepatic and pancre-
atic resection have been included (i.e. full blood count, renal func-
tion, liver function and coagulation screen). Previous datasets
have demonstrated these data to be poorly collected. Despite this,
the literature suggests that serum investigations are useful predic-
tors of early outcome. This has consequences for the design of any
data collection mechanism. Data entry is likely to be enhanced by
classifying serum results as ‘normal’ or ‘abnormal’, or by checking
the ranges into which they fall (e.g. for serum albumin: <30 g/dl;
30–35 g/dl, and >35 g/dl), rather than by inserting absolute values.
In summary, the development of a risk adjustment model from
the data fields identified in this review will allow for the identifi-
cation of those factors with most influence on early outcome and
will thus identify potential targets for preoperative optimization,
and facilitate the development of a multicentre risk prediction
model. The majority of the current literature focuses on retro-
spective single-centre studies and is therefore of limited value.
Future prospective studies, preferably multicentre, are necessary
to validate these individual risk factors in order to determine
relative impact and to subsequently validate any risk adjustment
model.
The AUGIS Hepatobiliary and Pancreatic Cancer Surgery
Audit is shortly to be launched online. For more information,
please contact David Berry (david.berry@uhl-tr.nhs.uk).
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Appendix
Liver search terms
1 Liver or hepatic
2 Cancer or metastases or hepatocellular carcinoma or HCC or cholangiocarcinoma or gallbladder cancer or Klatskin tumour
3 Operation or resection or surgery
4 Outcome or risk or operative risk or surgical risk or risk adjustment
1 AND 2 AND 3 AND 4
Potentially relevant studies 
identified and screened for 
retrieval (n = 9539) 
Studies retrieved for more 
detailed evaluation (n = 511) 
Studies excluded at abstract
stage (n = 9028) 
Potentially appropriate studies
to be included (n = 128) 
Studies with usable
information (n = 63) 
Studies excluded (n = 383)* 
Studies excluded for not using
multivariate analysis (n = 65) 
*Not resection surgery, did not investigate specified outcome measures
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Pancreas search terms
1 Pancreatic or pancreas or ampullary or biliary or cholangiocarcinoma
2 Cancer
3 Operation or resection or surgery
4 Outcome or risk or operative risk or surgical risk or risk adjustment
1 AND 2 AND 3 AND 4
Potentially relevant studies
identified and screened for
retrieval (n = 7167)
Studies retrieved for more
detailed evaluation (n = 852)
Studies excluded at
abstract stage (n = 6315)
Potentially appropriate studies
to be included (n = 146) 
Studies with usable
information (n = 68)
Studies excluded (n = 706)*
Studies excluded for not using
multivariate analysis (n = 78)
*Not resection surgery, did not investigate specified outcome measures, not cancer surgery
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